APP下载

米氮平治疗老年抑郁症效果及其对血清脑源性神经营养因子的影响

2014-11-17张玉琦陈炯华

中国医药导报 2014年29期
关键词:抑郁症老年

张玉琦 陈炯华(等)

[摘要] 目的 探讨米氮平治疗老年抑郁症的临床效果和安全性及其对血清脑源性神经营养因子(BDNF)的影响。 方法 2011年12月~2013年10月就诊于南京医科大学附属精神卫生中心,符合《中国精神疾病分类方案与诊断标准》第3版(CCMD-3)抑郁症诊断标准的老年抑郁症患者62例,进行为期8周的开放性米氮平治疗,以汉密尔顿抑郁量表(HAMD)和临床疗效总评量表(CGI)为评估临床疗效的工具。在入组时和8周的开放性治疗结束时检测BDNF。 结果 完成研究的老年抑郁症患者58例,所用米氮平的平均剂量为(31.3±7.8)mg/d。米氮平治疗8周后HAMD总分、病情严重程度、疗效总评和疗效指数与治疗前相比明显下降,差异有高度统计学意义(P < 0.01);治疗后体重稍有增加,但差异无统计学意义(P > 0.05);BDNF较治疗前明显升高,差异有高度统计学意义(P < 0.01)。副作用主要为过度镇静、入睡时下肢不适、头晕、腹泻。 结论 米氮平治疗老年抑郁症安全、有效,能提高BDNF水平。

[关键词] 老年;抑郁症;米氮平;脑源性神经营养因子

[中图分类号] R749.3 [文献标识码] A [文章编号] 1673-7210(2014)10(b)-0064-05

Effect on efficacy and BDNF of Mirtazapine in elderly patients with major depression

ZHANG Yuqi1▲ CHEN Jionghua2 LI Guilin1 ZHANG Feng1 CHEN Caixia1 XIA Minghua1 ZHANG Changsong3 ZHAO Xingfu1▲

1.Department of Geriatric Psychiatry, Wuxi Mental Health Center Affiliated to Nanjing Medical University, Jiangsu Province, Wuxi 214151, China; 2.Department of Brain, Jiangsu Province Academy of Traditional Chinese Medicine, Jiangsu Province, Nanjing 210028, China; 3.Department of Laboratory Medicine, Changzhou Tumor Hospital of Soochow University, Jiangsu Province, Changzhou 213000, China

[Abstract] Objective To investigate the clinical efficacy and safety of Mirtazapine in treatment of elderly depression and impact on serum brain-derived neurotrophic factor (BDNF). Methods From December 2011 to October 2013 for treatment at Wuxi Mental Health Center Affiliated to Nanjing Medical University, 62 elders who met diagnostic criteria for major depression in Chinese Classification of Mental Disorders (CCMD-3) were treated with Mirtazapine for 8 weeks, Hamilton depression scale (HAMD) and clinical global impression (CGI) were used to assess clinical efficacy of Mirtazapine. Serum BDNF at enrolled and after 8 weeks of open treatment was detected. Results Fifty eight patients completed the study, the mean dose of Mirtazapine was (31.3±7.8) mg/d. After 8 weeks of Mirtazapine treatment, HAMD total score, severity of illness, global improvement and efficacy index were decreased significantly compared with before treatment (P < 0.01). The body weight slight increased after treatment, but the difference was not statistically significant (P > 0.05). BDNF was statistically significant higher than pre-treatment (P < 0.01). The main side effects were excessive sedation, lower extremity discomfort when falling asleep, dizziness, and diarrhea. Conclusion Mirtazapine in treatment of elderly depression is safe and effective, and it can increase BDNF levels.

[Key words] Elderly; Major depression; Mirtazapine; BDNF

越来越多的证据表明,老年抑郁症的临床症状群与中青年相比有较大的临床差异,症状多样化,趋于不典型,除临床具有显著的抑郁心境外,失眠、焦虑、易激惹等症状较为突出[1],老年人经历空巢和配偶的离世更可能发生严重的抑郁症状[2],并且常常因伴发躯体疾病和难以耐受药物不良反应而中断治疗,存在更高的自杀风险[1,3-5],给患者本人和家庭带来痛苦,严重影响老年人的生活质量[5]。许多老年抑郁患者还具有双相性[6],更增加了临床治疗的难度。血清脑源性神经营养因子(BDNF)在抑郁症患者是降低的,并且与其症状的严重程度呈负相关[7-8]。……

登录APP查看全文

猜你喜欢

抑郁症老年
三种抗抑郁症药物治疗伴躯体疼痛症状的抑郁症患者的对比研究
综合分析老年精神科患者的临床特点
盐酸氨溴索联合头孢曲松他唑巴坦钠治疗老年急性肺炎的临床疗效
对一例因抑郁症有自杀倾向的案例分析
老年帕金森病非运动症状与日常生活自理能力的关系及护理分析
文拉法辛联合米氮平治疗老年抑郁症的效果及安全性
喉罩全麻在老年下腹部短小手术中的应用
西酞普兰治疗抑郁症的疗效及安全性
人工关节置换和内固定治疗老年股骨粗隆间骨折的效果分析
抑郁症患者脑电图检查的临床应用